Transdermal Nicotine Therapy and Primary Care: Importance of Counseling, Demographic, and Participant Selection Factors on 1-Year Quit Rates

作者: David Daughton , Jeffrey Susman , Michael Sitorius , Sergei Belenky , Tajuddin Millatmal

DOI: 10.1001/ARCHFAMI.7.5.425

关键词:

摘要: OBJECTIVE To evaluate the smoking cessation efficacy of nicotine patch therapy as an adjunct to low-intensity, primary care intervention. DESIGN Randomized, placebo-controlled, double-blind, multisite trial. SETTINGS Twenty-one sites in Nebraska. PATIENTS A total 369 smokers 20 or more cigarettes per day. INTERVENTION Two brief visits for intervention with 10 weeks active placebo-patch therapy. MAIN OUTCOME MEASURES Confirmed self-reported abstinence 3, 6, and 12 months after quit RESULTS Compared placebo control subjects, participants assigned patches had higher 3-month (23.4% vs 11.4%; P = 7), 1-year rates were significantly group (19.1%) compared (5.0%) (chi 2 10.7; .001). However, there was no significant difference low Fagerstrom scores (< 7). CONCLUSIONS Nicotine enhanced 6 month The highest achieved by who specifically contacted site enroll study obtain a prescription patches. Differences participant selection factors may account, part, lower associated Duration counseling, patient age, be important related long-term success

参考文章(9)
Jerome L. Schwartz, Review and evaluation of smoking cessation methods : the United States and Canada, 1978-1985 Division of Cancer Prevention and Control, National Cancer Institute, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health , For sale by the Supt. of Docs., U.S. G.P.O.. ,(1987)
S. L. Kenford, Predicting smoking cessation. Who will quit with and without the nicotine patch JAMA: The Journal of the American Medical Association. ,vol. 271, pp. 589- 594 ,(1994) , 10.1001/JAMA.271.8.589
Karen M. Emmons, Michael G. Goldstein, Smokers who are hospitalized: a window of opportunity for cessation interventions. Preventive Medicine. ,vol. 21, pp. 262- 269 ,(1992) , 10.1016/0091-7435(92)90024-C
F.J. Kviz, M.A. Clark, K.S. Crittenden, R.B. Warnecke, S. Freels, Age and smoking cessation behaviors. Preventive Medicine. ,vol. 24, pp. 297- 307 ,(1995) , 10.1006/PMED.1995.1048
John A. Stapleton, Colin Feyerabend, Gunnar Gustavsson, Debbie Wiseman, Urbain Sawe, Simon M Wiseman, Michael A. H. Russell, Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice Addiction. ,vol. 90, pp. 31- 42 ,(1995) , 10.1046/J.1360-0443.1995.901316.X
Jed E Rose, Edward D Levin, Frederique M Behm, Carla Adivi, Cynthia Schur, Transdermal nicotine facilitates smoking cessation Clinical Pharmacology & Therapeutics. ,vol. 47, pp. 323- 330 ,(1990) , 10.1038/CLPT.1990.35
Philip Tonnesen, Jesper Norregaard, Kåre Simonsen, Urbain Säwe, A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking Cessation New England Journal of Medicine. ,vol. 325, pp. 311- 315 ,(1991) , 10.1056/NEJM199108013250503
P Yudkin, D Mant, M Bartlett, M Thorogood, A Fuller, G Fowler, R Wilson, S Wood, D Thurston, A Chivers, M Nichols, D Stern, K Lindsey, J Clements, J Tissier, R Harrington, K Kealey, K Agnew, D Ebbs, J Hodgeman, N Maclennan, H Vanoss, I Eastwood, M Dawes, R Godlee, L Jones, R Stevens, J Murray, P Burke, W Dobbie, RANDOMIZED TRIAL OF NICOTINE PATCHES IN GENERAL-PRACTICE - RESULTS AT ONE-YEAR BMJ. ,vol. 308, pp. 1476- 1477 ,(1994)